BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Suppiah A, Greenman J. Clinical utility of anti-p53 auto-antibody: Systematic review and focus on colorectal cancer. World J Gastroenterol 2013; 19(29): 4651-4670 [PMID: 23922463 DOI: 10.3748/wjg.v19.i29.4651]
URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4651.htm
Number Citing Articles
1
Julia Butt, William J. Blot, Lauren R. Teras, Kala Visvanathan, Loïc Le Marchand, Christopher A. Haiman, Yu Chen, Ying Bao, Howard D. Sesso, Sylvia Wassertheil-Smoller, Gloria Y. Ho, Lesley F. Tinker, Richard M. Peek, John D. Potter, Timothy L. Cover, Laura H. Hendrix, Li-Ching Huang, Tim Waterboer, Michael Pawlita, Meira Epplein. Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort ConsortiumCancer Epidemiology Biomarkers & Prevention 2018; 27(10): 1186 doi: 10.1158/1055-9965.EPI-18-0249
2
Kazutaka Kojima, Junichi Shindoh, Miho Akabane, Ryosuke Umino, Yuta Kobayashi, Satoshi Okubo, Masaji Hashimoto. Usefulness of Serum Anti-p53 Antibody Measurement in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesWorld Journal of Surgery 2021; 45(6): 1906 doi: 10.1007/s00268-021-06049-9
3
Zachary R. Fritz, Rene S. Schloss, Martin L. Yarmush, Lawrence J. Williams. HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibodyBioorganic & Medicinal Chemistry Letters 2021; 51: 128341 doi: 10.1016/j.bmcl.2021.128341
4
Jian-Xiang Shi, Jie-Jie Qin, Hua Ye, Peng Wang, Kai-Juan Wang, Jian-Ying Zhang. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysisExpert Review of Molecular Diagnostics 2015; 15(6): 829 doi: 10.1586/14737159.2015.1035713
5
Arjelle Decasa Agupitan, Paul Neeson, Scott Williams, Jason Howitt, Sue Haupt, Ygal Haupt. P53: A Guardian of Immunity Becomes Its Saboteur through MutationInternational Journal of Molecular Sciences 2020; 21(10): 3452 doi: 10.3390/ijms21103452
6
Elena N. Voropaeva, Mikhail I. Voevoda, Tatiana I. Pospelova, Vladimir N. Maksimov. Prognostic impact of theTP53rs1625895 polymorphism in DLBCL patientsBritish Journal of Haematology 2015; 169(1): 32 doi: 10.1111/bjh.13237
7
Lauren R. Teras, Susan M. Gapstur, Maret L. Maliniak, Eric J. Jacobs, Ted Gansler, Angelika Michel, Michael Pawlita, Tim Waterboer, Peter T. Campbell. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal CancerCancer Epidemiology Biomarkers & Prevention 2018; 27(2): 219 doi: 10.1158/1055-9965.EPI-17-0407
8
Karīna Siliņa, Undīne Rulle, Zane Kalniņa, Aija Linē. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Cancer Immunology, Immunotherapy 2014; 63(7): 643 doi: 10.1007/s00262-014-1544-9
9
Hao Sun, Jian-Xiang Shi, Hong-Fei Zhang, Meng-Tao Xing, Pei Li, Li-Ping Dai, Cheng-Lin Luo, Xiao Wang, Peng Wang, Hua Ye, Liu-Xia Li, Jian-Ying Zhang. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancerTumor Biology 2017; 39(6): 101042831769913 doi: 10.1177/1010428317699132
10
Yu Hong, Jian Huang. Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(11): 1581-1585 doi: 10.4254/wjh.v7.i11.1581
11
K. Walczak, J. Olszewski, K. Domeradzka- Gajda, P. Politański, M. Zmyślony, K. Kowalczyk, M. Stępnik. Micronuclei frequency in peripheral blood lymphocytes and levels of anti-p53 autoantibodies in serum of residents of Kowary city regions (Poland) with elevated indoor concentrations of radonMutation Research/Genetic Toxicology and Environmental Mutagenesis 2019; 838: 67 doi: 10.1016/j.mrgentox.2018.12.007
12
Hans Raskov, Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg. Colorectal carcinogenesis-update and perspectivesWorld Journal of Gastroenterology 2014; 20(48): 18151-18164 doi: 10.3748/wjg.v20.i48.18151
13
Koji Hontani, Takahiro Tsuchikawa, Takaki Hiwasa, Toru Nakamura, Takashi Ueno, Toshihiro Kushibiki, Mizuna Takahashi, Kazuho Inoko, Hironobu Takano, Satoshi Takeuchi, Hirotoshi Dosaka-Akita, Masaki Kuwatani, Naoya Sakamoto, Yutaka Hatanaka, Tomoko Mitsuhashi, Hideaki Shimada, Toshiaki Shichinohe, Satoshi Hirano. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumorsOncotarget 2017; 8(63): 106206 doi: 10.18632/oncotarget.22175
14
Asmaa M. El-Rasikh, Haithem A. M. Farghali, Hisham A. Abdelrahman, Mostafa Elgaffary, Shaymaa Abdelmalek, Ibrahim A. Emam, Magdy A. Ghoneim, Salah A. Selim. The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89894-x
15
Saptaka Baruah, Bidyarani Maibam, Sanjeev Kumar. Biosensor Based Advanced Cancer Diagnostics2022; : 257 doi: 10.1016/B978-0-12-823424-2.00023-5
16
Benjamin A. Katchman, Rodrigo Barderas, Rizwan Alam, Diego Chowell, Matthew S. Field, Laura J. Esserman, Garrick Wallstrom, Joshua LaBaer, Daniel W. Cramer, Michael A. Hollingsworth, Karen S. Anderson. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancersPROTEOMICS - Clinical Applications 2016; 10(7): 720 doi: 10.1002/prca.201500096
17
Feng Zhao, Mei Cao, Xiao-Hui Jiang, Ke Xie, Shang-Rong Ye, Shang-Mian Yie. A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinomaBiomarkers 2020; 25(2): 149 doi: 10.1080/1354750X.2020.1714734
18
Shinya Abe, Kazushige Kawai, Soichiro Ishihara, Hiroaki Nozawa, Keisuke Hata, Tomomichi Kiyomatsu, Toshiaki Tanaka, Takeshi Nishikawa, Kensuke Ootani, Koji Yasuda, Koji Murono, Toshiaki Watanabe. Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective StudyOncology 2017; 92(1): 31 doi: 10.1159/000449527
19
Isabel K. Macdonald, Celine B. Parsy-Kowalska, Caroline J. Chapman. Autoantibodies: Opportunities for Early Cancer DetectionTrends in Cancer 2017; 3(3): 198 doi: 10.1016/j.trecan.2017.02.003
20
Maja Sirotković-Skerlev, Natalija Dedić Plavetić, Filip Sedlić, Sanja Kusačić Kuna, Damir Vrbanec, Borislav Belev, Stjepko Pleština, Zdenko Kovač, Ana Kulić. Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years)Cancer Biomarkers 2021; 30(1): 95 doi: 10.3233/CBM-201497
21
María Garranzo-Asensio, Ana Guzmán-Aránguez, Carmen Povés, María Jesús Fernández-Aceñero, Ana Montero-Calle, María Ángeles Ceron, Servando Fernandez-Diez, Nuria Rodríguez, Marta Gómez de Cedrón, Ana Ramírez de Molina, Gemma Domínguez, Rodrigo Barderas. The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 proteinScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49960-x
22
Claudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello, Francesco Novelli. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerMolecules 2021; 26(6): 1642 doi: 10.3390/molecules26061642
23
Anke Vanderstraeten, Tina Everaert, Rieta Van Bree, Godelieve Verbist, Cathérine Luyten, Frederic Amant, Sandra Tuyaerts. In Vitro Validation of Survivin as Target Tumor-associated Antigen for Immunotherapy in Uterine CancerJournal of Immunotherapy 2015; 38(6): 239 doi: 10.1097/CJI.0000000000000085
24
Chenguang Li, Mingxiao Chen, Pingwei Zhao, Desalegn Admassu Ayana, Lei Wang, Yanfang Jiang. Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancerExperimental and Therapeutic Medicine 2016; 12(2): 589 doi: 10.3892/etm.2016.3424
25
Hualin Fu, Daxiang Cui. Gastric Cancer Prewarning and Early Diagnosis SystemTranslational Medicine Research 2017; : 11 doi: 10.1007/978-94-024-0951-2_2
26
Mengtao Xing, Xinzhi Wang, Robert A. Kiken, Ling He, Jian-Ying Zhang. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and TreatmentInternational Journal of Molecular Sciences 2021; 22(11): 6139 doi: 10.3390/ijms22116139
27
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Naoya Yoshida, Hideo Baba. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatmentSurgery Today 2017; 47(5): 636 doi: 10.1007/s00595-016-1464-8
28
Hugo de Jonge, Luisa Iamele, Maristella Maggi, Greta Pessino, Claudia Scotti. Anti-Cancer Auto-Antibodies: Roles, Applications and Open IssuesCancers 2021; 13(4): 813 doi: 10.3390/cancers13040813
29
Marica Garziera, Marcella Montico, Ettore Bidoli, Simona Scalone, Roberto Sorio, Giorgio Giorda, Emilio Lucia, Giuseppe Toffoli, Hiromu Suzuki. Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-AnalysisPLOS ONE 2015; 10(10): e0140351 doi: 10.1371/journal.pone.0140351
30
Yang Li, Cheng-qiang Li, Shu-juan Guo, Wei Guo, He-wei Jiang, He-cheng Li, Sheng-ce Tao. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinomaEBioMedicine 2020; 53: 102674 doi: 10.1016/j.ebiom.2020.102674
31
Isamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, Hisashi Gunji, Fumitaka Ishige, Yosuke Iwatate, Fumiaki Shiratori, Satoshi Yajima, Rei Okada, Hideaki Shimada. Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancersAnnals of Gastroenterological Surgery 2020; 4(3): 275 doi: 10.1002/ags3.12325
32
Henry A. Adeola, Muneerah Smith, Lisa Kaestner, Jonathan M. Blackburn, Luiz F. Zerbini. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohortOncotarget 2016; 7(12): 13945 doi: 10.18632/oncotarget.7359
33
Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Fumiaki Shiratori, Kimihiko Funahashi, Shinichi Kawai, Toshihiro Nanki, Sei Muraoka, Yoshihisa Urita, Yoshihisa Saida, Shinichi Okazumi, Yuko Kitagawa, Yuki Hirata, Hirotoshi Hasegawa, Koji Okabayashi, Masahiko Murakami, Takeshi Yamashita, Rei Kato, Hisahiro Matsubara, Kentaro Murakami, Yasuaki Nakajima, Hironobu Sugita, Martin Klammer, Hideaki Shimada. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional StudyAnnals of Surgical Oncology 2021; 28(7): 4007 doi: 10.1245/s10434-020-09342-4
34
Simone Werner, Friedemann Krause, Vinzent Rolny, Matthias Strobl, David Morgenstern, Christian Datz, Hongda Chen, Hermann Brenner. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening SettingClinical Cancer Research 2016; 22(7): 1725 doi: 10.1158/1078-0432.CCR-15-1268
35
Hiroki Osumi, Eiji Shinozaki, Mitsukuni Suenaga, Yosuke Kumekawa, Mariko Ogura, Masato Ozaka, Satoshi Matsusaka, Keisho Chin, Noriko Yamamoto, Nobuyuki Mizunuma. Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1751-6
36
Makoto Kobayashi, Hiroyuki Katayama, Johannes F. Fahrmann, Samir M. Hanash. Development of autoantibody signatures for common cancersSeminars in Immunology 2020; 47: 101388 doi: 10.1016/j.smim.2020.101388
37
Cristovao F. Lima, Marta Costa, M.F. Proença, Cristina Pereira-Wilson. Novel structurally similar chromene derivatives with opposing effects on p53 and apoptosis mechanisms in colorectal HCT116 cancer cellsEuropean Journal of Pharmaceutical Sciences 2015; 72: 34 doi: 10.1016/j.ejps.2015.02.019
38
Tino W. Sanchez, Guangyu Zhang, Jitian Li, Liping Dai, Saied Mirshahidi, Nathan R. Wall, Clayton Yates, Colwick Wilson, Susanne Montgomery, Jian-Ying Zhang, Carlos A. Casiano. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated ProteinsMolecular & Cellular Proteomics 2016; 15(12): 3564 doi: 10.1074/mcp.M116.060244
39
Rongqin Meng, Yang Wang, Liang He, Yuanqing He, Zedong Du. Potential diagnostic value of serum p53 antibody for detecting colorectal cancer: A meta-analysisOncology Letters 2018;  doi: 10.3892/ol.2018.8070